Merck To Create Company To Sell Its Older, Slower Growth Products Focusing Heavily On Women’s Health Drugs

Merck's rivals Pfizer and GlaxoSmithKline have made similar moves. In addition to women’s health medicines and older, off-patent brands, the new business will include the less expensive versions of branded biotech drugs. In other pharmaceutical news: a multiple sclerosis drug, patents for HIV prevention pills, recalls, biotech news and more.

from Kaiser Health News https://ift.tt/2S4ovOO